Total Share Holders Equity (after Deducting Minority Equity)
1,849,376,401
1,451,641,002
27.4
Profit (Loss) per Share
5.93
2.53
All figures are in (Actual) Saudi Arabia, Riyals
Element List
Explanation
The reason of the increase (decrease) in the net profit during the current year compared to the last year is
Net profit increases in general due to:1. Gain from discontinued operation.2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticals.b) Specialty chemical.c) Steel industries.3. Decrease in foreign exchange and hyperinflation in the following sectors:a) Pharmaceuticals.b) Specialty chemical.4. Decrease in provision for impairment of financial assets in the following sectors:a) Specialty chemical.b) Steel industries.c) Other.While noting that there is increase in general and administrative expenses and selling and distribution expenses in all sectors.
Statement of the type of external auditor’s report
Unmodified opinion
Reclassification of Comparison Items
Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information
1. Net Shareholders’ Equity at the end of the period was SR 1,913,185,390/- compared to SR 1,504,091,847 /- at the end of the similar period last year with an increase of 27%.2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 33 of the consolidated financial statements for further details.
Total Share Holders Equity (after Deducting Minority Equity)
1,715,582,380
1,395,581,237
22.93
Profit (Loss) per Share
4.86
1.88
All figures are in (Actual) Saudi Arabia, Riyals
ELEMENT LIST
EXPLANATION
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is
Net profit increases in general due to:1. Decrease in selling and distribution expenses in the Pharmaceuticals sector2. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Other3. Increase in other income in the following sectors:c) Pharmaceuticalsd) Other4. Decrease in loss from discontinued operationWhile noting that there is decrease in gross profit in the Pharmaceuticals sector.
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is
Net profit decrease in general due to:1. Previous quarter included gain from discontinued operation2. Decrease in gross profit in the following sectors:a) Specialty chemicalb) PharmaceuticalsGross profit decrease was partially offset by increase in gross profit in power and steel sector.3. Increase in general and administrative expenses in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Increase in provision for impairment of financial assets expense in the following sectors:a) Pharmaceuticalsb) Power and steelWhile noting that there is increase in other income in Pharmaceuticals and Other sector.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is
Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in other expenses in pharmaceuticals sector.3. Increase in sales and gross profit in the following sectors:a) Specialty chemicalb) Pharmaceuticals4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in pharmaceuticals sector.
Statement of the type of external auditor’s report
Unmodified conclusion
Reclassification of Comparison Items
Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information
1. Net Shareholders’ Equity at the end of the period was SR 1,714,921,175 /- compared to SR 1,448,185,342 /- at the end of the similar period last year with an increase of 18%.2. With the completion of the sale of Al Anmaa during the nine month period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details.
Total Share Holders Equity (after Deducting Minority Equity)
1,644,592,701
1,352,372,354
21.61
Profit (Loss) per Share
3.97
1.32
All figures are in (Actual) Saudi Arabia, Riyals
ELEMENT LIST
EXPLANATION
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is
Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous quarter of the current year is
Net profit increases in general due to:1. Gain from discontinued operation2. Decrease in selling and distribution expenses in pharmaceuticals sector.3. Decrease in general and administrative expenses in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) OtherWhile noting that there is decrease in gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemicalc) Power and steel
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is
Net profit increases in general due to:1. Gain from discontinued operation2. Increase in sales and gross profit in the following sectors:a) Pharmaceuticalsb) Specialty chemical3. Decrease in other expenses in pharmaceuticals sector.4. Decrease in provision for impairment of financial assets in all sectors.While noting that there is increase in selling and distribution expenses and general and administrative expenses in all sectors.
Statement of the type of external auditor’s report
Unmodified conclusion
Reclassification of Comparison Items
Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information
1. Net Shareholders’ Equity at the end of the period was SR1,644,232,915/- compared to SR1,407,057,157/- at the end of the similar period last year with an increase of 17%.2. With the completion of the sale of Al Anmaa during the period, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed interim consolidated financial statements for further details.
With reference to Astra Industrial Group announcement on 08/02/2022 G ) corresponding to 07/07/1443 H) and further update on 25/04/2022 G ) corresponding to 24/09/1443 H) related to one of its subsidiaries, Al Tanmiya For Steel Industries (Al Tanmiya) owned 65% by the group, has signed a conditional agreement on 07/02/2022 G (corresponding to 06/07/1443 H) with Al-Ghad Al-Mutakamel Company for General Trading, Iron, Steel and Metal Industries for exiting its investment in Alanmaa Company for General Construction Materials Industry Limited (Alanmaa Company), which owns steel and power plants in Iraq, we would like to announce that the company has finalized the accounting treatment with various auditors and reached an estimate on the gain as a result of this transaction.
Previous Announcement
Astra Industrial Group (Astra) announces an update on its announcement that one of its subsidiaries, Al Tanmiya for Steel Industries (Al Tanmiya), signed a conditional agreement for exiting its investment in Alanmaa For Construction Materials Production Ltd. (Alanmaa)
Date of Previous Announcement on Tadawul’s Website
2022-04-25 Corresponding to 1443-09-24
Percentage of fulfilled achievement
In compliance with IFRS standards, Astra Industrial Group and its subsidiary, Tanmiah, had to accrue estimated tax liability and expenses that will be imposed on the sale of Alanmaa.As the Group has completed the estimation of these expenses and tax liabilities and has cleared accounting treatment with the auditors of Astra Industrial Group and Tanmiya, we would like to announce to the public that the results of second quarter will include consolidated gain of SR182.9M from the sale of Alanmaa of which the group share is SR170.2M as per international financial reporting standards and reporting requirements in the related countries.For future update or progress on the process completion of discontinued operation accounting treatment and best estimates of transaction expenses, please refer to the subsequent quarterly and yearly group financial statements
Event’s Expected Completion Date
04/08/2022
Reasons for Exceeding the Announced End Date
N/A
The costs associated with the event, and if they have changed or not with indication of the reasons.
N/A
Impact of the Delay on the Company’s Financial Results
Total Share Holders Equity (after Deducting Minority Equity)
1,526,364,666
1,363,871,382
11.914
Profit (Loss) per Share
0.93
0.63
All figures are in (Actual) Saudi Arabia, Riyals
ELEMENT LIST
EXPLANATION
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is
Net profit increases in general due to:1. Increase in sales in the following sectors:a. Pharmaceuticalsb. Specialty chemical2. Decrease in other expenses in pharmaceuticals sector.3. Decrease in provision for impairment of financial assets in pharmaceuticals sector.While noting that there is increase in selling and distribution expenses and general and administrative expenses in pharmaceuticals sector.
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous period of the current year is
Net profit increases in general due to:1. Increase in sales and gross profit in the following sectors:a. Pharmaceuticalsb. Specialty chemical2. Decrease in other expenses in pharmaceuticals sector.While noting that there is increase in selling and distribution expenses in pharmaceuticals sector and increase in provision for impairment of financial assets in pharmaceuticals and specialty chemical sectors.
Statement of the type of external auditor’s report
Unmodified conclusion
Reclassification of Comparison Items
Certain comparative figures for the previous period have been reclassified to be consistent with the presentation of the current period.
Additional Information
1. Net Shareholders’ Equity at the end of the period was SR1,579,544,902/- compared to SR1,421,009,316/- at the end of the similar period last year with an increase of 11%.2. With the completion of the sale of Al Anmaa subsequent to 31st March 2022, the financial results and statements of Al Tanmiya were accounted for in accordance with IFRS requirements. Please refer to Note 13 of the condensed consolidated interim financial statements for further details.
The Board of Directors of Astra Industrial Group is pleased to invite the shareholders to participate and vote in the Extraordinary General Assembly (First Meeting) which will be held on Thursday 21/04/2022 at 9:00PM via modern technology means using Tadawulaty System.
City and Location of the General Assembly’s Meeting
By means of modern technology – AIG Headquarter – Riyadh
Shareholders Registered in the Issuer’s Shareholders Registry in the Depository Centre At the End of the Trading Session Preceding the General Assembly’s Meeting as per Laws and Regulations
Quorum for Convening the General Assembly’s Meeting
The Meeting of the Extraordinary General Assembly shall be valid only in the presence of shareholders representing half of the company’s capital. In the event that this quorum is not available in the first meeting, the second meeting will be held an hour after the end of the period specified for the first meeting, and the second meeting will be valid if attended by a number of shareholders representing at least a quarter of company’s capital.
General Assembly Meeting Agenda
Attached
Proxy Form
E-Vote
The shareholders who are registered in Tadawulaty Services can remotely vote on the Items of the Extraordinary General Assembly starting from 10:00 AM on Monday 18/04/2022G and continue until the end of the Extraordinary General Assembly Meeting’s time, noting that registration and voting via Tadawulaty Services will be available and free of charge through the following link: www.tadawulaty.com.sa
Eligibility for Attendance Registration and Voting
Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes
Method of Communication
For inquiries, please contact the Investors relations department on +966114752002 ext. 139, also you can direct your inquiries to the email of the investor relations department on: Khaled.albalawi@aig.sa
Attached Documents
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
